Attached files
| file | filename |
|---|---|
| 10-Q - ANIKA THERAPEUTICS, INC. 10-Q - Anika Therapeutics, Inc. | a6090041.htm |
| EX-31.2 - EXHIBIT 31.2 - Anika Therapeutics, Inc. | a6090041ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anika Therapeutics, Inc. | a6090041ex31_1.htm |
Exhibit 32.1
Section 906
Certification
The
undersigned officers of Anika Therapeutics, Inc. (the “Company”) hereby
certify to their knowledge and in their respective capacities that the Company’s
quarterly report on Form 10-Q to which this certification is attached (the
“Report”), as filed with the Securities and Exchange Commission on the date
hereof, fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.
|
Date:
November 3, 2009
|
/s/
CHARLES H. SHERWOOD
|
|
Charles
H. Sherwood, Ph.D.
|
|
|
Chief
Executive Officer
|
|
|
/s/
KEVIN W. QUINLAN
|
|
|
Kevin
W. Quinlan
|
|
|
Chief
Financial Officer
|
This
certification shall not be deemed “filed” for any purpose, nor shall it be
deemed to be incorporated by reference into any filing, under the Securities Act
of 1933, as amended, or the Exchange Act.